A digital platform to help find and enroll patients in clinical trials for rare kidney diseases
Official title: A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases
Funded at Nephropathology Associates · NIH-10930152 · Data updated 2026-11-12
This study is working on a new mobile app called Arkana Connect™ to help doctors find and enroll patients with rare kidney diseases in clinical trials more easily, so that those patients can get the best possible treatment options.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nephropathology Associates NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $950,283 |
| NIH project number | 5R44DK138688-02 |
| Project ID | NIH-10930152 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with rare kidney diseases who may benefit from participation in clinical trials.
✕Less likely to help
Patients with common kidney diseases or those not eligible for clinical trials may not receive any benefit from this research.
What this research studies
This research aims to create a digital platform that enhances the identification and enrollment of patients in clinical trials specifically for rare kidney diseases. By leveraging advanced nephropathology insights, the platform will streamline the recruitment process, which is often hindered by the complexity of these conditions. The approach involves utilizing a mobile app, Arkana Connect™, that allows clinicians to track patient biopsies and access pathology reports, facilitating better communication and patient matching. This innovative method is designed to improve the efficiency of clinical trials and ensure that patients with rare kidney diseases are accurately identified and enrolled.
Why it matters
Potential benefit: If successful, this research could significantly improve access to clinical trials for patients with rare kidney diseases, leading to better treatment options.
How similar studies have gone: Other research has shown success with digital platforms for patient recruitment in clinical trials, indicating that this approach has potential for effectiveness.
Where this research is happening
-
Nephropathology Associates
Little Rock, United States Active
Researchers
- Principal investigator: Larsen, Christopher P — Nephropathology Associates
- Study coordinator: Larsen, Christopher P
Related research
Other NIH-funded projects on the same topics.
-
Chronic Kidney Disease of Unknown Cause in Agricultural Communities
A wide study to find what causes a serious kidney disease that affects workers in farming areas, by looking at people in high-risk regions.
-
Ubiquitin D as a potential target to help NASH, kidney disease, and liver cancer
A new approach targets a protein called UBD to help people with fatty liver disease, kidney disease, and liver cancer that can arise from liver disease.
-
Metabolic Boost to Kidney Health in ADPKD
A Johns Hopkins-led study is exploring how fueling kidney cells with fats and FGF21 signals could slow kidney disease in adults with ADPKD.
-
Graph-based spatial transcriptomics AI methods to understand kidney diseases
Aims to create AI-powered tools to map where kidney cells are and how they communicate, helping people with chronic kidney disease (CKD) or acute kidney injury (AKI).
-
How APOL1 gene changes can lead to kidney damage
Researchers are exploring how APOL1 gene changes found mainly in people of African ancestry can harm kidney cells and contribute to certain non-diabetic chronic kidney diseases.
-
Understanding Ubiquitin D for Liver and Kidney Diseases
This project looks at a protein called Ubiquitin D to find new ways to help people with liver conditions like NASH and HCC, and also chronic kidney disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.